Jump to content

Recommended Posts

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Similar Topics

    • By NASA
      Teams with NASA are gaining momentum as work progresses toward future lunar missions for the benefit of humanity as numerous flight hardware shipments from across the world arrived at the agency’s Kennedy Space Center in Florida for the first crewed Artemis flight test and follow-on lunar missions. The skyline at Kennedy will soon see added structures as teams build up the ground systems needed to support them.
      Crews are well underway with parallel preparations for the Artemis II flight, as well as buildup of NASA’s mobile launcher 2 tower for use during the launch of the SLS (Space Launch System) Block 1B rocket, beginning with the Artemis IV mission. This version of NASA’s rocket will use a more powerful upper stage to launch with crew and more cargo on lunar missions. Technicians have begun upper stage umbilical connections testing that will help supply fuel and other commodities to the rocket while at the launch pad.
      In summer 2024, technicians from NASA and contractor Bechtel National, Inc. completed a milestone called jack and set, where the center’s mega-mover, the crawler transporter, repositioned the initial steel base assembly for mobile launcher 2 from temporary construction shoring to its six permanent pedestals near the Kennedy’s Vehicle Assembly Building.   
      Teams at Bechtel National, Inc. use a crane to lift Module 4 into place atop the mobile launcher 2 tower chair at its park site on Jan. 3, 2025, at Kennedy Space Center in Florida. Module 4 is the first of seven modules that will be stacked vertically to make up the almost 400-foot launch tower that will be used beginning with the Artemis IV mission.Betchel National Inc./Allison Sijgers “The NASA Bechtel mobile launcher 2 team is ahead of schedule and gaining momentum by the day,” stated Darrell Foster, ground systems integration manager, NASA’s Exploration Ground Systems Program at NASA Kennedy. “In parallel to all of the progress at our main build site, the remaining tower modules are assembled and outfitted at a second construction site on center.”
      As construction of the mobile launcher 2’s base continues, the assembly operations shift into integration of the modules that will make up the tower. In mid-October 2024, crews completed installation of the chair, named for its resemblance to a giant seat. The chair serves as the interface between the base deck and the vertical modules which are the components that will make up the tower, and stands at 80-feet-tall.
      In December 2024, teams completed the rig and set Module 4 operation where the first of a total of seven 40-foot-tall modules was stacked on top of the chair. Becthel crews rigged the module to a heavy lift crane, raised the module more than 150-feet, and secured the four corners to the tower chair. Once complete, the entire mobile launcher structure will reach a height of nearly 400 feet – approximately the length of four Olympic-sized swimming pools placed end-to-end.
      On the opposite side of the center, test teams at the Launch Equipment Test Facility are testing the new umbilical interfaces, which will be located on mobile launcher 2, that will be needed to support the new SLS Block 1B Exploration Upper Stage. The umbilicals are connecting lines that provide fuel, oxidizer, pneumatic pressure, instrumentation, and electrical connections from the mobile launcher to the upper stage and other elements of SLS and NASA’s Orion spacecraft.
      “All ambient temperature testing has been successfully completed and the team is now beginning cryogenic testing, where liquid nitrogen and liquid hydrogen will flow through the umbilicals to verify acceptable performance,” stated Kevin Jumper, lab manager, NASA Launch Equipment Test Facility at Kennedy. “The Exploration Upper Stage umbilical team has made significant progress on check-out and verification testing of the mobile launcher 2 umbilicals.”
      https://www.nasa.gov/wp-content/uploads/2025/01/eusu-test-3-5b-run-1.mp4 Exploration Upper Stage Umbilical retract testing is underway at the Launch Equipment Test Facility at Kennedy Space Center in Florida on Oct. 22, 2024. The new umbilical interface will be used beginning with the Artemis IV mission. Credit: LASSO Contract LETF Video Group The testing includes extension and retraction of the Exploration Upper Stage umbilical arms that will be installed on mobile launcher 2. The test team remotely triggers the umbilical arms to retract, ensuring the ground and flight umbilical plates separate as expected, simulating the operation that will be performed at lift off.
      View the full article
    • By European Space Agency
      The European Space Agency’s Milky Way-mapper Gaia has completed the sky-scanning phase of its mission, racking up more than three trillion observations of about two billion stars and other objects over the last decade to revolutionise the view of our home galaxy and cosmic neighbourhood.
      View the full article
    • By NASA
      Firefly Aerospace’s Blue Ghost lander getting encapsulated in SpaceX’s rocket fairing ahead of the planned liftoff for 1:11 a.m. EST Jan. 15 from Launch Complex 39A at NASA’s Kennedy Space Center in FloridaSpaceX As part of NASA’s CLPS (Commercial Lunar Payload Services) initiative and Artemis campaign, the agency is preparing to fly ten instruments aboard Firefly Aerospace’s first delivery to the Moon. These science payloads and technology demonstrations will help advance our understanding of the Moon and planetary processes, while paving the way for future crewed missions on the Moon and beyond, for the benefit of all.
      Firefly’s lunar lander, named Blue Ghost, is scheduled to launch on a SpaceX Falcon 9 rocket Wednesday, Jan.15, from Launch Complex 39A at NASA’s Kennedy Space Center in Florida. After a 45-day cruise phase, Blue Ghost is targeted to land near a volcanic feature called Mons Latreille within Mare Crisium, a basin approximately 340 miles wide (550 kilometers) located in the northeast quadrant of the Moon’s near side.
      How can we enable more precise navigation on the Moon? How do spacecraft interact with the lunar surface? How does Earth’s magnetic field influence the effects of space weather on our home planet? NASA’s instruments on this flight will conduct first-of-their-kind demonstrations to help answer these questions and more, including testing regolith sampling technologies, lunar subsurface drilling capabilities, increasing precision of positioning and navigation abilities, testing radiation tolerant computing, and learning how to mitigate lunar dust during lunar landings.

      The ten NASA payloads aboard Firefly’s Blue Ghost lander include:

      Lunar Instrumentation for Subsurface Thermal Exploration with Rapidity (LISTER) will measure heat flow from the Moon’s interior by measuring the thermal gradient, or changes in temperature at various depths, and thermal conductivity, or the subsurface material’s ability to let heat pass through it. LISTER will take several measurements up to 10 feet deep using pneumatic drilling technology with a custom heat flow needle instrument at its tip. Data from LISTER will help scientists retrace the Moon’s thermal history and understand how it formed and cooled. Lead organization: Texas Tech University
      Lunar PlanetVac (LPV) is designed to collect regolith samples from the lunar surface using a burst of compressed gas to drive the regolith into a sample chamber (sieving) for collection and analysis by various instruments. Additional instrumentation will then transmit the results back to Earth. The LPV payload is designed to help increase the science return from planetary missions by testing low-cost technologies for collecting regolith samples in-situ. Lead organization: Honeybee Robotics
      Next Generation Lunar Retroreflector (NGLR) serves as a target for lasers on Earth to precisely measure the distance between Earth and the Moon by reflecting very short laser pulses from Earth-based Lunar Laser Ranging Observatories. The laser pulse transit time to the Moon and back is used to determine the distance. Data from NGLR could improve the accuracy of our lunar coordinate system and contribute to our understanding of the inner structure of the Moon and fundamental physics questions. Lead organization: University of Maryland
      Regolith Adherence Characterization (RAC) will determine how lunar regolith sticks to a range of materials exposed to the Moon’s environment throughout the lunar day. RAC will measure accumulation rates of lunar regolith on surfaces (for example, solar cells, optical systems, coatings, and sensors) through imaging to determine their ability to repel or shed lunar dust. The data captured will help test, improve, and protect spacecraft, spacesuits, and habitats from abrasive regolith. Lead organization: Aegis Aerospace
      Radiation Tolerant Computer (RadPC) will demonstrate a computer that can recover from faults caused by ionizing radiation. Several RadPC prototypes have been tested aboard the International Space Station and Earth-orbiting satellites, but this flight will provide the biggest trial yet by demonstrating the computer’s ability to withstand space radiation as it passes through Earth’s radiation belts, while in transit to the Moon, and on the lunar surface. Lead organization: Montana State University
      Electrodynamic Dust Shield (EDS) is an active dust mitigation technology that uses electric fields to move and prevent hazardous lunar dust accumulation on surfaces. EDS is designed to lift, transport, and remove particles from surfaces with no moving parts. Multiple tests will demonstrate the feasibility of the self-cleaning glasses and thermal radiator surfaces on the Moon. In the event the surfaces do not receive dust during landing, EDS has the capability to re-dust itself using the same technology. Lead organization: NASA’s Kennedy Space Center
      Lunar Environment heliospheric X-ray Imager (LEXI) will capture a series of X-ray images to study the interaction of solar wind and Earth’s magnetic field that drives geomagnetic disturbances and storms. Deployed and operated on the lunar surface, this instrument will provide the first global images showing the edge of Earth’s magnetic field for critical insights into how space weather and other cosmic forces surrounding our planet impact Earth. Lead organizations: Boston University, NASA’s Goddard Space Flight Center, and Johns Hopkins University
      Lunar Magnetotelluric Sounder (LMS) will characterize the structure and composition of the Moon’s mantle by measuring electric and magnetic fields. This investigation will help determine the Moon’s temperature structure and thermal evolution to understand how the Moon has cooled and chemically differentiated since it formed. Lead organization: Southwest Research Institute
      Lunar GNSS Receiver Experiment (LuGRE) will demonstrate the possibility of acquiring and tracking signals from GNSS (Global Navigation Satellite System) constellations, specifically GPS and Galileo, during transit to the Moon, during lunar orbit, and on the lunar surface. If successful, LuGRE will be the first pathfinder for future lunar spacecraft to use existing Earth-based navigation constellations to autonomously and accurately estimate their position, velocity, and time. Lead organizations: NASA Goddard, Italian Space Agency
      Stereo Camera for Lunar Plume-Surface Studies (SCALPSS) will use stereo imaging photogrammetry to capture the impact of the rocket exhaust plume on lunar regolith as the lander descends on the Moon’s surface. The high-resolution stereo images will aid in creating models to predict lunar regolith erosion, which is an important task as bigger, heavier spacecraft and hardware are delivered to the Moon in close proximity to each other. This instrument also flew on Intuitive Machines’ first CLPS delivery. Lead organization: NASA’s Langley Research Center 
      Through the CLPS initiative, NASA purchases lunar landing and surface operations services from American companies. The agency uses CLPS to send scientific instruments and technology demonstrations to advance capabilities for science, exploration, or commercial development of the Moon. By supporting a robust cadence of lunar deliveries, NASA will continue to enable a growing lunar economy while leveraging the entrepreneurial innovation of the commercial space industry.

      Learn more about CLPS and Artemis at: http://www.nasa.gov/clps 

      Alise Fisher
      Headquarters, Washington
      202-358-2546
      alise.m.fisher@nasa.gov

      Natalia Riusech / Nilufar Ramji  
      Johnson Space Center, Houston 
      281-483-5111 
      natalia.s.riusech@nasa.gov / nilufar.ramji@nasa.gov
      View the full article
    • By NASA
      6 min read
      Preparations for Next Moonwalk Simulations Underway (and Underwater)
      In-person participants L-R standing: Dave Francisco, Joanne Kaouk, Dr. Richard Moon, Dr. Tony Alleman, Dr. Sean Hardy, Sarah Childress, Kristin Coffey, Dr. Ed Powers, Dr. Doug Ebersole, Dr. Steven Laurie, Dr. Doug Ebert; L-R seated: Dr. Alejandro Garbino, Dr. Robert Sanders, Dr. Kristi Ray, Dr. Mike Gernhardt, Dr. Joseph Dervay, Dr. Matt Makowski). Not pictured: Dr. Caroline Fife In June 2024, the NASA Office of the Chief Health and Medical Officer (OCHMO) Standards Team hosted an independent assessment working group to review the status and progress of research and clinical activities intended to mitigate the risk of decompression sickness (DCS) related to patent foramen ovale (PFO) during spaceflight and associated ground testing and human subject studies.
      Decompression sickness (DCS) is a condition which results from dissolved gases (primarily nitrogen) forming bubbles in the bloodstream and tissues. It is usually experienced in conditions where there are rapid decreases in ambient pressure, such as in scuba divers, high-altitude aviation, or other pressurized environments. The evolved gas bubbles have various physiological effects and can obstruct the blood vessels, trigger inflammation, and damage tissue, resulting in symptoms of DCS. NASA presently classifies DCS into two categories: Type I DCS, which is less severe, typically leads to musculoskeletal symptoms including pain in the joints or muscles, or skin rash. Type II DCS is more severe and commonly results in neurological, inner ear, and cardiopulmonary symptoms. The risk of DCS in spaceflight presents during extravehicular activities (EVAs) in which astronauts perform mission tasks outside the spaceflight vehicle while wearing a pressurized suit at a lower pressure than the cabin pressure. DCS mitigation protocols based on strategies to reduce systemic nitrogen load are implemented through the combination of habitat environmental parameters, EVA suit pressure, and breathing gas procedures (prebreathe protocols) to achieve safe and effective mission operations. The pathophysiology of DCS has still not been fully elucidated since cases occur despite the absence of detected gas bubbles but includes right to left shunting of venous gas emboli (VGE) via several potential mechanisms, one of which is a Patent Foramen Ovale (PFO).
      From: Dr. Schochet & Dr. Lie, Pediatric Pulmonologists
      Reference OCHMO-TB-037 Decompression Sickness (DCS) Risk Mitigation technical brief for additional information.
      A PFO is a shunt between the right atrium and the left atrium of the heart, which is a persisting remnant of a physiological communication present in the fetal heart. Post-natal increases in left atrial pressure usually force the inter-septal valve against the septum secundum and within the first 2 years of life, the septae permanently fuse due to the development of fibrous adhesions. Thus, all humans are born with a PFO and approximately 75% of PFOs fuse following childbirth. For the 25% of the population’s whose PFOs do not fuse, ~6% have what is considered by some to be a large PFO (> 2 mm). PFO diameter can increase with age. The concern with PFOs is that with a right to left shunt between the atria, venous emboli gas may pass from the right atrium (venous) to the left atrium (arterial) (“shunt”), thus by-passing the normal lung filtration of venous emboli which prevent passage to the arterial system. Without filtration, bubbles in the arterial system may lead to a neurological event such as a stroke. Any activity that increases the right atrium/venous pressure over the left atrium/arterial pressure (such as a Valsalva maneuver, abdominal compression) may further enable blood and/or emboli across a PFO/shunt.
      From: Nuffield Department of Clinical Neurosciences
      The purpose of this working group was to review and provide analysis on the status and progress of research and clinical activities intended to mitigate the risk of PFO and DCS issues during spaceflight. Identified cases of DCS during NASA exploration atmosphere ground testing conducted in pressurized chambers led to the prioritization of the given topic for external review. The main goals of the working group included:
      Quantification of any increased risk associated with the presence of a PFO during decompression protocols utilized in ground testing and spaceflight EVAs, as well as unplanned decompressions (e.g., cabin depressurization, EVA suit leak). Describe risks and benefits of PFO screening in astronaut candidates, current crewmembers, and chamber test subjects. What are potential risk reduction measures that could be considered if a person was believed to be at increased risk of DCS due to a PFO? What research and/or technology development is recommended that could help inform and/or mitigate PFO-related DCS risk? The working group took place over two days at NASA’s Johnson Space Center and included NASA subject matter experts and stakeholders, as well as invited external reviewers from areas including cardiology, hypobaric medicine, spaceflight medicine, and military occupational health. During the working group, participants were asked to review past reports and evidence related to PFOs and risk of DCS, materials and information regarding NASA’s current experience and practices, and case studies and subsequent decision-making processes. The working group culminated in an open-forum discussion where recommendations for current and future practices were conferred and subsequently summarized in a final summary report, available on the public NASA OCHMO Standards Team website.
      The following key findings are the main take-aways from the OCHMO independent assessment:
      In an extreme exposure/high-risk scenario, excluding individuals with a PFO and treating PFOs does not necessarily decrease the risk of DCS or create a ‘safe’ environment. It may create incremental differences and slightly reduce overall risk but does not make the risk zero. There are other physiological factors that also contribute to the risk of DCS that may have a larger impact (see 7.0 Other Physiological Factors in the findings section).  Based on the available evidence and the risk of current decompression exposures (based on current NASA protocols and NASA-STD-3001 requirements to limit the risk of DCS), it is not recommended to screen for PFOs in any spaceflight or ground testing participants. The best strategy to reduce the risk of DCS is to create as safe an environment as possible in every scenario, through effective prebreathe protocols, safety, and the capability to rapidly treat DCS should symptoms occur.  Based on opinion, no specific research is required at this time to further characterize PFOs with DCS and altitude exposure, due to the low risk and preference to institute adequate safe protocols and ensuring treatment availability both on the ground and in spaceflight. For engineering protocols conducted on the ground, it should be ensured that the same level of treatment capability (treatment chamber in the immediate vicinity of the testing) is provided as during research protocols. The ability to immediately treat a DCS case is critical in ensuring the safety of the test subjects. The full summary report includes detailed background information, discussion points from the working group, and conclusions and recommendations. The findings from the working group and resulting summary report will help to inform key stakeholders in decision-making processes for future ground testing and spaceflight operations with the main goal of protecting crew health and safety to ensure overall mission success.
      Summary Report About the Author
      Sarah D. Childress

      Share
      Details
      Last Updated Dec 31, 2024 Related Terms
      Office of the Chief Health and Medical Officer (OCHMO) Human Health and Performance Humans in Space International Space Station (ISS) Explore More
      2 min read Station Science Top News: Dec. 20, 2024
      Article 2 weeks ago 4 min read Artemis II Core Stage Vertical Integration Begins at NASA Kennedy
      Article 2 weeks ago 3 min read NASA, Axiom Space Change Assembly Order of Commercial Space Station
      Article 2 weeks ago Keep Exploring Discover More Topics From NASA
      Missions
      Humans in Space
      Climate Change
      Solar System
      View the full article
    • By European Space Agency
      What’s harder than flying a single satellite in Earth orbit? Flying two – right beside each other, at proximities that would normally trigger collision avoidance manoeuvres. 
      View the full article
  • Check out these Videos

×
×
  • Create New...